Patents Examined by Ramond J Henley, III
  • Patent number: 10828271
    Abstract: The present invention provides a method for treating pleuroperitoneal membrane cancers, and comprises: delivering disulfiram or a derivative thereof that is effective in amount in the treatment, into the pleura and/or the peritoneum of a test person that needs to be treated. The present invention also provides a pharmaceutical component comprising the disulfiram or the derivative thereof, and a reagent kit.
    Type: Grant
    Filed: April 13, 2017
    Date of Patent: November 10, 2020
    Assignee: UNIVERSITY OF WOLVERHAMPTON
    Inventors: Weiguang Wang, Zhipeng Wang